PRIMA-1 induces autophagy in cancer cells carrying mutant or wild type p53

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 8, 2013, Pages 1904-1913

  Russo, Debora ^a   Ottaggio, Laura ^a   Foggetti, Giorgia ^a   Masini, Matilde ^b   Masiello, Pellegrino ^b   Fronza, Gilberto ^a   Menichini, Paola ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Autophagy; Electron microscopy; LC3; P53; PRIMA 1

Indexed keywords

ACRIDINE; ANTINEOPLASTIC AGENT; PRIMA 1; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL PROLIFERATION; CELL STRAIN HCT116; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; PRIORITY JOURNAL;

AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; HCT116 CELLS; HUMANS; MEMBRANE PROTEINS; MUTATION; NEOPLASMS; NERVE TISSUE PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877907992     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.03.020     Document Type: Article

References (47)

1. Selivanova G., Wiman K.G. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Oncogene 2007, 26:2243-2254.
2. Bykov V.J., Issaeva N., Selivanova G., Wiman K.G. Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database. Carcinogenesis 2002, 23:2011-2018.
3. Lambert J.M., Gorzov P., Veprintsev D.B., Soderqvist M., Segerback D., Bergman J., Fersht A.R., Hainaut P., Wiman K.G., Bykov V.J. PRIMA-1 reactivates mutant p53 by covalent binding to the core domain. Cancer Cell 2009, 15:376-388.
4. Chipuk J.E., Maurer U., Green D.R., Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 2003, 4:371-381.
5. Shen J., Vakifahmetoglu H., Stridh H., Zhivotovsky B., Wiman K.G. PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2. Oncogene 2008, 27:6571-6580.
6. Lambert J.M., Moshfegh A., Hainaut P., Wiman K.G., Bykov V.J. Mutant p53 reactivation by PRIMA-1(MET) induces multiple signaling pathways converging on apoptosis. Oncogene 2009, 29:1329-1338.
7. Koong A.C., Chauhan V., Romero-Ramirez L. Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biol. Ther. 2006, 5:756-759.
8. Li J., Lee B., Lee A.S. Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J. Biol. Chem. 2006, 281:7260-7270.
9. Rokaeus N., Klein G., Wiman K.G., Szekely L., Mattsson K. PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins. Oncogene 2007, 26:982-992.
10. Russo D., Ottaggio L., Penna I., Foggetti G., Fronza G., Inga A., Menichini P. PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells. Biochem. Biophys. Res. Commun. 2010, 402:345-350.
11. He S., Yaung J., Kim Y.H., Barron E., Ryan S.J., Hinton D.R. Endoplasmic reticulum stress induced by oxidative stress in retinal pigment epithelial cells. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:677-683.
12. Santos C.X., Tanaka L.Y., Wosniak J., Laurindo F.R. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 2009, 11:2409-2427.
13. Oakes S.A., Lin S.S., Bassik M.C. The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr. Mol. Med. 2006, 6:99-109.
14. Hetz C.A. ER stress signaling and the BCL-2 family of proteins: from adaptation to irreversible cellular damage. Antioxid. Redox Signal. 2007, 9:2345-2355.
15. Heath-Engel H.M., Chang N.C., Shore G.C. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene 2008, 27:6419-6433.
16. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
17. Mizushima N. Autophagy: process and function. Genes Dev. 2007, 21:2861-2873.
18. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
19. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8:741-752.
20. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
21. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., Jung J.U. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
22. Levine B. Cell biology: autophagy and cancer. Nature 2007, 446:745-747.
23. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
24. Vousden K.H., Lane D.P. P53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
25. Maiuri M.C., Galluzzi L., Morselli E., Kepp O., Malik S.A., Kroemer G. Autophagy regulation by p53. Curr. Opin. Cell Biol. 2010, 22:181-185.
26. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., Criollo A., Morselli E., Zhu C., Harper F., Nannmark U., Samara C., Pinton P., Vicencio J.M., Carnuccio R., Moll U.M., Madeo F., Paterlini-Brechot P., Rizzuto R., Szabadkai G., Pierron G., Blomgren K., Tavernarakis N., Codogno P., Cecconi F., Kroemer G. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10:676-687.
27. Crighton D., Wilkinson S., O'Prey J., Syed N., Smith P., Harrison P.R., Gasco M., Garrone O., Crook T., Ryan K.M. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006, 126:121-134.
28. Bartek J., Iggo R., Gannon J., Lane D.P. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990, 5:893-899.
29. Magrini R., Russo D., Ottaggio L., Fronza G., Inga A., Menichini P. PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. J. Cell. Biochem. 2008, 104:2363-2373.
30. Gallo R., Gambelli F., Gava B., Sasdelli F., Tellone V., Masini M., Marchetti P., Dotta F., Sorrentino V. Generation and expansion of multipotent mesenchymal progenitor cells from cultured human pancreatic islets. Cell Death Differ. 2007, 14:1860-1871.
31. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
32. Weibel E.R. Stereological Methods 1979, Academic Press, New York London.
33. Marchetti P., Del Guerra S., Marselli L., Lupi R., Masini M., Pollera M., Bugliani M., Boggi U., Vistoli F., Mosca F., Del Prato S. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J. Clin. Endocrinol. Metab. 2004, 89:5535-5541.
34. Abassi Y.A., Xi B., Zhang W., Ye P., Kirstein S.L., Gaylord M.R., Feinstein S.C., Wang X., Xu X. Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects. Chem. Biol. 2009, 16:712-723.
35. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M., Sphicas E., Domingo D., Yahalom J. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001, 61:439-444.
36. Kanzawa T., Kondo Y., Ito H., Kondo S., Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 2003, 63:2103-2108.
37. Kanzawa T., Germano I.M., Komata T., Ito H., Kondo Y., Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11:448-457.
38. Takeuchi H., Kondo Y., Fujiwara K., Kanzawa T., Aoki H., Mills G.B., Kondo S. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 2005, 65:3336-3346.
39. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
40. Tanida I., Minematsu-Ikeguchi N., Ueno T., Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 2005, 1:84-91.
41. Lehmann S., Bykov V.J., Ali D., Andren O., Cherif H., Tidefelt U., Uggla B., Yachnin J., Juliusson G., Moshfegh A., Paul C., Wiman K.G., Andersson P.O. Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. J. Clin. Oncol. 2012, 30:3633-3639.
42. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93.
43. Baehrecke E.H. Autophagy: dual roles in life and death?. Nat. Rev. Mol. Cell Biol. 2005, 6:505-510.
44. Shen S., Kepp O., Kroemer G. The end of autophagic cell death?. Autophagy 2012, 8:1-3.
45. Eisenberg-Lerner A., Bialik S., Simon H.U., Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009, 16:966-975.
46. Ding W.X., Ni H.M., Gao W., Hou Y.F., Melan M.A., Chen X., Stolz D.B., Shao Z.M., Yin X.M. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J. Biol. Chem. 2007, 282:4702-4710.
47. Orrenius S., Kaminskyy V.O., Zhivotovsky B. Autophagy in toxicology: cause or consequence?. Annu. Rev. Pharmacol. Toxicol. 2012.